Performance

ARQT +8.13%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
ARQT	+2.54%	-9.78%	+8.13%	+3.50%	-37.50%	0.36	0.00%

Summary

ARQT at a glance

ARQT returned +8.13% over the past year and +3.50% a year over five years. Its worst drop in that year was -37.50%, smaller than 42% of stocks on Redstone, and its Sharpe ratio of 0.36 beats 44% of stocks on Redstone. It pays no dividends.

Ranking

How ARQT ranks

Current Drawdown

-23.05%

Rolling Volatility

96.33%

Actions

Metrics

Risk Indicators

Alpha6.09%

Beta1.43x

Sharpe0.36

Sortino0.51

Omega1.07

Calmar0.22

Martin1.07

Profile

About ARQT

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $3.3B
Listed: Jan 2020
Employees: 354
Headquarters: Westlake Village, CA
Website: arcutis.com

Comparisons

ARQT: Arcutis Biotherapeutics, Inc.

ARQT at a glance

How ARQT ranks

Current Drawdown

Rolling Volatility

About ARQT

Related comparisons